Down 9.8%: Is Masimo Corporation Stock a Contrarian Buy?
Masimo Corporation (NASDAQ: MASI), a mid-cap medical technology company, reported stronger-than-expected second-quarter results after the bell Wednesday, but investors still decided to hit the exits en mass Thursday. Specifically, the company's shares fell by 9.8% yesterday on nearly three times the average volume.
Image source: Getty Images.
The really perplexing part of this downward move is that Masimo's management even boosted the company's annual revenue guidance by $10 million to $769 million during its second-quarter earnings release. Moreover, Masimo doesn't sport any major red flags -- such as unsightly debt levels or weakening product sales -- to easily explain this overtly negative reaction to the company's exceptionally strong second-quarter earnings report.
Source: Fool.com
Masimo Corp. Aktie
Positive Tendenz bei Masimo Corp. mit mehreren Buy-Einschätzungen als Sell-Einschätzungen.
Ein Kursziel von 147 € für Masimo Corp. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 99.8 € bedeuten.
